Video Experimental Relacionado
Updated: Jun 14, 2026
23:56
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Acceso a medicamentos pediátricos en Albania: un estudio cualitativo de las percepciones de los médicos de familia
Eriona Petro1,2, Hendrika A van den Ham2, Aukje K Mantel-Teeuwisse2
1Local Healthcare Unit, Durres, Albania.
PLOS global public health
|February 10, 2026
Resumen
El acceso a los medicamentos pediátricos esenciales en Albania se ve obstaculizado por el costo, la escasez y la selección limitada, lo que afecta la salud infantil. Abordar estas barreras requiere regulaciones actualizadas y políticas de reembolso para un mejor acceso a la atención médica.
Área de la Ciencia:
- Servicios de salud Servicios de salud Investigación Investigación.
- Farmacología Pediátrica.
- El sistema de salud albanés.
Sus antecedentes:
- El acceso a la medicación pediátrica es un problema crítico en Albania, que afecta a los resultados de la salud infantil.
- Los médicos de familia se enfrentan a desafíos significativos al prescribir y proporcionar tratamientos pediátricos apropiados.
Objetivo del estudio:
- Explorar las perspectivas de los médicos de familia sobre la accesibilidad de la medicina pediátrica en Albania.
- Identificar las principales barreras y facilitadores que afectan el acceso a los medicamentos pediátricos.
Principales métodos:
- Entrevistas semiestructuradas llevadas a cabo con 18 médicos de familia en Durrës, Albania.
- El análisis de datos utilizó el marco de la cadena de valor farmacéutica para el rigor metodológico.
Principales resultados:
- Los prescriptores informaron de barreras que incluyen cuestiones regulatorias, fijación de precios, selección limitada, adquisiciones y desafíos de reembolso.
- La asequibilidad fue una preocupación importante, influyendo en la prescripción, con frecuentes escaseces de antibióticos.
- Los facilitadores incluyeron el asesoramiento efectivo del paciente y la comunicación prescriptor-farmacéutico.
Conclusiones:
- Múltiples obstáculos percibidos por los prescriptores impiden el acceso a la medicina pediátrica en Albania.
- La aplicación de las regulaciones de prescripción y la actualización de las políticas de reembolso son cruciales para mejorar los resultados de la salud infantil.
Videos de Conceptos Relacionados
01:02Prescription, Nonprescription and Orphan Drugs
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...